Literature DB >> 24954822

Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease.

Eva Szigethy1, Simona I Bujoreanu2, Ada O Youk3, John Weisz4, David Benhayon3, Diane Fairclough5, Peter Ducharme2, Joseph Gonzalez-Heydrich2, David Keljo3, Arvind Srinath3, Athos Bousvaros2, Margaret Kirshner3, Melissa Newara3, David Kupfer3, David R DeMaso2.   

Abstract

OBJECTIVE: Pediatric inflammatory bowel disease (IBD) is associated with high rates of depression. This study compared the efficacy of cognitive behavioral therapy (CBT) to supportive nondirective therapy (SNDT) in treating youth with comorbid IBD and depression.
METHOD: Youth (51% female and 49% male; age 9-17 years, mean age 14.3 years) with depression and Crohn's disease (n = 161) or ulcerative colitis (n = 56) were randomly assigned to a 3-month course of CBT or SNDT. The primary outcome was comparative reduction in depressive symptom severity; secondary outcomes were depression remission, increase in depression response, and improved health-related adjustment and IBD activity.
RESULTS: A total of 178 participants (82%) completed the 3-month intervention. Both psychotherapies resulted in significant reductions in total Children's Depression Rating Scale Revised score (37.3% for CBT and 31.9% for SNDT), but the difference between the 2 treatments was not significant (p = .16). There were large pre-post effect sizes for each treatment (d = 1.31 for CBT and d = 1.30 for SNDT). More than 65% of youth had a complete remission of depression at 3 months, with no difference between CBT and SNDT (67.8% and 63.2%, respectively). Compared to SNDT, CBT was associated with a greater reduction in IBD activity (p = .04) but no greater improvement on the Clinical Global Assessment Scale (p = .06) and health-related quality of life (IMPACT-III scale) (p = .07).
CONCLUSION: This is the first randomized controlled study to suggest improvements in depression severity, global functioning, quality of life, and disease activity in a physically ill pediatric cohort treated with psychotherapy. Clinical trial registration information-Reducing Depressive Symptoms in Physically Ill Youth; http://clinical trials.gov; NCT00534911.
Copyright © 2014 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  depression; inflammatory bowel disease; physical illness; psychotherapy; quality of life

Mesh:

Year:  2014        PMID: 24954822      PMCID: PMC4104185          DOI: 10.1016/j.jaac.2014.04.014

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  41 in total

1.  Assessing secondary control and its association with youth depression symptoms.

Authors:  John R Weisz; Sarah E Francis; Sarah Kate Bearman
Journal:  J Abnorm Child Psychol       Date:  2010-10

2.  The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case-note audit.

Authors:  Antonina A Mikocka-Walus; Andrea L Gordon; Benjamin J Stewart; Jane M Andrews
Journal:  J Psychosom Res       Date:  2011-07-29       Impact factor: 3.006

3.  Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression.

Authors:  Eva Szigethy; Elyse Kenney; Johanna Carpenter; Diana M Hardy; Diane Fairclough; Athos Bousvaros; David Keljo; John Weisz; William R Beardslee; Robert Noll; David Ray DeMASO
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-10       Impact factor: 8.829

4.  Adjustment to inflammatory bowel disease: the relative influence of illness perceptions and coping.

Authors:  Angela Dorrian; Martin Dempster; Pauline Adair
Journal:  Inflamm Bowel Dis       Date:  2009-01       Impact factor: 5.325

5.  Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease.

Authors:  Wendy N Gray; Lee A Denson; Robert N Baldassano; Kevin A Hommel
Journal:  Inflamm Bowel Dis       Date:  2010-11-04       Impact factor: 5.325

6.  Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria.

Authors: 
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-07       Impact factor: 2.839

7.  A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy.

Authors:  D A Brent; D Holder; D Kolko; B Birmaher; M Baugher; C Roth; S Iyengar; B A Johnson
Journal:  Arch Gen Psychiatry       Date:  1997-09

8.  Using problem-solving skills training to reduce negative affectivity in mothers of children with newly diagnosed cancer: report of a multisite randomized trial.

Authors:  Olle Jane Z Sahler; Diane L Fairclough; Sean Phipps; Raymond K Mulhern; Michael J Dolgin; Robert B Noll; Ernest R Katz; James W Varni; Donna R Copeland; Robert W Butler
Journal:  J Consult Clin Psychol       Date:  2005-04

9.  A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease.

Authors:  Rachel Neff Greenley; Kevin A Hommel; Justin Nebel; Tara Raboin; Shun-Hwa Li; Pippa Simpson; Laura Mackner
Journal:  J Pediatr Psychol       Date:  2010-02-01

10.  Therapist success and its determinants.

Authors:  L Luborsky; A T McLellan; G E Woody; C P O'Brien; A Auerbach
Journal:  Arch Gen Psychiatry       Date:  1985-06
View more
  38 in total

1.  Family-based interpersonal psychotherapy for depressed preadolescents: examining efficacy and potential treatment mechanisms.

Authors:  Laura J Dietz; Rebecca J Weinberg; David A Brent; Laura Mufson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-12-30       Impact factor: 8.829

2.  Depression Predicts Prolonged Length of Hospital Stay in Pediatric Inflammatory Bowel Disease.

Authors:  Perseus V Patel; Matthew S Pantell; Melvin B Heyman; Sofia Verstraete
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-11       Impact factor: 2.839

3.  Effectiveness of Disease-Specific Cognitive Behavioral Therapy on Anxiety, Depression, and Quality of Life in Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial.

Authors:  Luuk Stapersma; Gertrude van den Brink; Jan van der Ende; Eva M Szigethy; Ruud Beukers; Thea A Korpershoek; Sabine D M Theuns-Valks; Manon H J Hillegers; Johanna C Escher; Elisabeth M W J Utens
Journal:  J Pediatr Psychol       Date:  2018-10-01

4.  Screening for Psychosocial and Family Risk in Pediatric Gastrointestinal Disorders.

Authors:  Carin Cunningham; Elise Cho; Michele L Shaffer; Miranda C Bradford; Tonya Palermo
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-12       Impact factor: 2.839

Review 5.  Evidence Base Update of Psychosocial Treatments for Child and Adolescent Depression.

Authors:  V Robin Weersing; Megan Jeffreys; Minh-Chau T Do; Karen T G Schwartz; Carl Bolano
Journal:  J Clin Child Adolesc Psychol       Date:  2016-11-21

6.  Considering the Bidirectional Pathways Between Depression and IBD: Recommendations for Comprehensive IBD Care.

Authors:  Laurie Keefer; Sunanda V Kane
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-03

Review 7.  Narcotic bowel syndrome and opioid-induced constipation.

Authors:  Eva Szigethy; Marc Schwartz; Douglas Drossman
Journal:  Curr Gastroenterol Rep       Date:  2014-10

Review 8.  Novel aspects of enteric serotonergic signaling in health and brain-gut disease.

Authors:  Andrew Del Colle; Narek Israelyan; Kara Gross Margolis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-04       Impact factor: 4.052

9.  The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease.

Authors:  Charles N Bernstein; Lixia Zhang; Lisa M Lix; Lesley A Graff; John R Walker; John D Fisk; Scott B Patten; Carol A Hitchon; James M Bolton; Jitender Sareen; Renée El-Gabalawy; James Marriott; Ruth Ann Marrie
Journal:  Inflamm Bowel Dis       Date:  2018-08-16       Impact factor: 5.325

10.  Depression Screening in Pediatric Inflammatory Bowel Disease Clinics: Recommendations and a Toolkit for Implementation.

Authors:  Laura M Mackner; Brandi N Whitaker; Michele H Maddux; Suzanne Thompson; Cheyenne Hughes-Reid; Megan Drovetta; Bonney Reed
Journal:  J Pediatr Gastroenterol Nutr       Date:  2020-01       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.